Columbia Engineering profiled Materialize New York, an accelerator led by Material Impact and Columbia Technology Ventures that gave students the opportunity to advance their lab research into a deeptech startup.
Allure Security, a Columbia startup developing cybersecurity software tools based on technology from the lab of Columbia's Dr. Salvatore Stolfo, closed a $10 million Series A funding round.
Gilgamesh Pharmaceuticals was awarded a multi-year $14M grant from the National Institute on Drug Abuse (NIDA) to develop GM-3009, its novel, cardiac-safe ibogaine analog for the treatment of substance use disorders. The startup is commercializing technology from the lab of Columbia's Dr. Dalibor Sames.
Gilgamesh Pharmaceuticals announced a new collaboration and option-to-license agreement with AbbVie aimed at developing novel transformative therapies for psychiatric disorders. The startup is commercializing technology from the lab of Columbia's Dr. Dalibor Sames.
olumbia startups Heirloom and 44.01 were named two of the finalist teams selected to compete in the last stage of XPRIZE Carbon Removal. Heirloom is based on a direct air capture system developed by Columbia's Dr. Peter Kelemen, and 44.01 uses technology developed by Dr. Peter Kelemen and Dr. Juerg Matter.
A research team led by Columbia's Dr. Clark T. Hung and Dr. Nadeen O. Chahine has been awarded nearly a $39M contract from the Advanced Research Projects Agency for Health (ARPA-H) to build living knee replacements from biomaterials and human stem cells, including a patient’s own cells. In order to meet the programmatic goals, the team will also be leveraging the expertise and resources of the Irving Institute for Clinical and Translational Research and Columbia Technology Ventures.
A new $100 million financing deal will help building owners install the Cozy, technology initially developed in the lab of Columbia's Dr. John Kymissis. Cozy units help to reduce the energy use from boilers.
CUIMC spotlighted Dr. Henry Colecraft's work as a scientist entrepreneur and the startups commercializing his engineered deubiquitinases technology.
ClearVision, a startup commercializing a non-invasive alternative to permanent vision-correction surgeries based on corneal sculpting with femtosecond laser technology developed by Columbia's Dr. Sinisa Vukelic, received $5K for second place at the SPIE Startup Challenge.
Columbia Technology Ventures’ pitch day gives center stage to startups emerging from the labs to the boardroom.
Peter Stern received The Bayh-Dole Coalition American Innovator Award for his work as CEO of Voyant Photonics, a startup commercializing technology developed by Columbia's Dr. Michal Lipson.
New York, NY, September 6, 2023
Columbia Technology Ventures and Material Impact, one of the world's leading investors in deep tech and advanced materials, today announced the launch of Materialize, an accelerator for deep technology startups. The goal of this program at Columbia Technology Ventures is to move advanced technologies from the academic lab that are ready to be spun out into successful startups.
Materialize is focused on Columbia's innovations that are solving large enduring needs in areas including biomanufacturing, sustainably-produced goods, sustainably-sourced…